Salmonellosis historical perspective: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 16: Line 16:
In 1884, Gaffkey isolated the bacterium in Germany, from the spleen of patients with the disease.
In 1884, Gaffkey isolated the bacterium in Germany, from the spleen of patients with the disease.


The first typhoid vaccine was only made in 1896 by Pfeiffer and Kalle, using  
The first typhoid vaccine was only made in 1896 by Pfeiffer and Kalle, using organisms killed by heat. Widal et all. also demonstrated on this year that sera from convalescent typhoid patients made the life organisms lose motility.
 


<!--
<!--
 
  Widal coined the term agglutinin to describe this observation. The antigenic classification or serotyping of Salmo- nella used today is a result of years of study of antibody interactions with bacterial surface antigens by Kauffman and White during the 1920s to 1940s.9 In 1948, Theodore Woodward and colleagues reported the suc- cessful treatment of Malaysian typhoid patients with chloromycetin,10 and the modern age of antimicrobial therapy for typhoid fever began. In 1952, Zinder and Lederberg, using S. Typhimurium, discovered genetic transduction, the transfer of genetic information from one cell to another by a virus particle (bacteriophage P22).11 Ames and co- workers in 1973 reported the development of the Ames test, which uses S. Typhimurium auxotrophic mutants to test the mutagenic activity of chemical compounds.12 At present Salmonella pathogenesis is studied widely in animal and tissue culture models of mammalian infection as an important model of host-parasite interactions.  
  In 1896, Pfeiffer and Kalle made the first typhoid vaccine with heat-killed organisms.7 In the same year Widal and others demonstrated that convalescent sera from typhoid patients caused the organisms to “stick together in large balls and lose their motility.”8 Widal coined the term agglutinin to describe this observation. The antigenic classification or serotyping of Salmo- nella used today is a result of years of study of antibody interactions with bacterial surface antigens by Kauffman and White during the 1920s to 1940s.9 In 1948, Theodore Woodward and colleagues reported the suc- cessful treatment of Malaysian typhoid patients with chloromycetin,10 and the modern age of antimicrobial therapy for typhoid fever began. In 1952, Zinder and Lederberg, using S. Typhimurium, discovered genetic transduction, the transfer of genetic information from one cell to another by a virus particle (bacteriophage P22).11 Ames and co- workers in 1973 reported the development of the Ames test, which uses S. Typhimurium auxotrophic mutants to test the mutagenic activity of chemical compounds.12 At present Salmonella pathogenesis is studied widely in animal and tissue culture models of mammalian infection as an important model of host-parasite interactions.  


-->
-->

Revision as of 20:21, 22 August 2014

Salmonellosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Salmonellosis from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Treatment

Medical Therapy

Primary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Salmonellosis historical perspective On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Salmonellosis historical perspective

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Salmonellosis historical perspective

CDC on Salmonellosis historical perspective

Salmonellosis historical perspective in the news

Blogs on Salmonellosis historical perspective

Directions to Hospitals Treating Salmonellosis

Risk calculators and risk factors for Salmonellosis historical perspective

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: João André Alves Silva, M.D. [2] Jolanta Marszalek, M.D. [3]

Overview

Historical Perspective

Salmonela was initially isolated from the intestines of pigs, by Salmon, an American veterinary pathologist. The bacteria was first associated with hog cholera by Theobald Smith in 1885. However, the disease was later discovered to be associated with a viral infection, with secondary infection due to Salmonella.

Typhoid fever was confused with typhus prior to the 19th century. It was only in 1829 that P. Luis, in Paris, after the studying the spleen and intestinal lymph nodes was able to distinguish typhoid from other types of fever. Additionally, P. Luis described the hemorrhage, intestinal perforation and rose spots related to the disease.

William Jenner, in 1850, was the first to question the difference between typhoid fever and typhus in the English literature. According to him, typhoid was associated with enlarged mesenteric lymph nodes and Peyer's patches. He also noted that history of typhoid protected the individual from further disease, which did not happen in typhus. The term enteric fever was first introduced by Wilson, who in 1869 suggested it after the anatomic region where infection occurred. Today both nomenclatures are used, with preference given to enteric fever.

The transmission of typhoid fever was only described in 1873 by Budd, who demonstrated that the disease could be transmitted by fomites, food and water.[1]

In 1884, Gaffkey isolated the bacterium in Germany, from the spleen of patients with the disease.

The first typhoid vaccine was only made in 1896 by Pfeiffer and Kalle, using organisms killed by heat. Widal et all. also demonstrated on this year that sera from convalescent typhoid patients made the life organisms lose motility.


References

  1. Budd W (1918). "TYPHOID FEVER ITS NATURE, MODE OF SPREADING, AND PREVENTION". Am J Public Health (N Y). 8 (8): 610–2. PMC 1362304. PMID 18009937.

Template:WikiDoc Sources